Sign Out
Each mL of concentrate for solution for infusion contains 150 mg of anifrolumab.
One vial of 2.0 mL of concentrate contains 300 mg of anifrolumab (150 mg/mL).
Anifrolumab is a human, immunoglobulin G1 kappa (IgG1κ) monoclonal antibody produced in mouse myeloma cells (NS0) by recombinant DNA technology.
Excipients/Inactive Ingredients: L-Histidine, L-Histidine hydrochloride monohydrate, L-Lysine hydrochloride, α,α- Trehalose dihydrate, Polysorbate 80, Water for injection (WFI).
